N&O 100
Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Drug Manufacturers - Other Sector (CIX: MSECTOR511)
2,249.95   UNCHANGED
Streaming Delayed Price  /  Updated: 7:30 AM EDT, May 21, 2013  /  Add to My Watchlist      
View: Sector News
All news about Drug Manufacturers - Other Sector
 
< Previous 1 2 3 4 5 6 Next >
Cantor Fitzgerald Upgrades Cubist Pharmaceuticals (CBST) to Hold
Today 7:07 EDT
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8356836 for the full story. Read More
from StreetInsider.com News Articles
U.S. court ruling favors Cubist in patent case versus Hospira
May 20, 2013
A federal court on Monday ruled in favor of Cubist Pharmaceuticals Inc on the interpretation of patent language in a case involving a generic challenge to its lead drug Cubicin by Hospira Inc . Read More
from FOX News
U.S. court ruling favors Cubist in patent case vs Hospira
May 20, 2013
May 20 (Reuters) - A U.S. federal court on Monday ruled in favor of Cubist Pharmaceuticals Inc on the interpretation of patent language in a case involving a generic challenge to its lead drug Cubicin... Read More
category companyNews
from Reuters: Company News
Interesting OPK Put And Call For July
May 20, 2013
Investors in Opko Health Inc (OPK) saw new options become available today, for the July expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the OPK options chain for the... Read More
category Stocks
from Market News Video
Pfizer halts study of lymphoma drug unlikely to help survival
May 20, 2013
May 20 (Reuters) - Pfizer Inc, which has been on a hot streak with three recent approvals of cancer drugs, stumbled on Monday, saying it was halting a late-stage trial of a drug for aggressive... Read More
category companyNews
from Reuters: Company News
Bio-Wire Equity Surveillance – Closing Bell 5/20/2013
May 20, 2013
Medium and large sized pharmaceutical companies were down by an average of .3-.6% at the closing bell Jumps by % Gain and Mkt Cap Change Biolife Solutions (OTC: BLFS) +34% on spike in trading activity... Read More
category RPTP , ACAD , MDXG , and 15 more.
from Bio-Wire.Com
UPDATE: Cubist Pharmaceuticals (CBST) Spikes to Session Highs
May 20, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8354934 for the full story. Read More
from StreetInsider.com News Articles
Bearish Moving Average Cross by Forest Laboratories (FRX)
May 20, 2013
from Comtex SmarTrend® News Briefs
Santarus, Inc. (NASDAQ:SNTS) and Rosetta Genomics, Ltd. (NASDAQ:ROSG) Added to Growing Stock Report's NASDAQ Gainers Watch List.
May 20, 2013
New York, NY -- (SBWIRE) -- 05/20/2013 -- Growing Stock Report expands its NASDAQ Gainers Weekly Watch List adding Santarus, Inc. (NASDAQ:SNTS) and Rosetta Genomics, Ltd. (NASDAQ:ROSG). Read More
from SBWire - Latest Press Releases
Enteromedics Rallies On Confirmed Path To Possible Approval
May 20, 2013
EnteroMedics (NASDAQ: ETRM) is a company that focuses on gastrointestinal and metabolic diseases with its flagship product VBLOC®, which is a first-in-class weight loss treatment that prevents obesity... Read More
category ETRM , Bio/Wire
from Bio-Wire.Com
$307,000-a-year Vertex Drug: Billions in Sales?
May 20, 2013
category VRTX
from YCharts
NASDAQ Decliners Watch List: Amarin Corporation Plc (NASDAQ:AMRN), Theravance Inc. (NASDAQ:THRX), and Dendreon Corp. (NASDAQ:DNDN) Added to Equity Profile Report's NASDAQ Decliners Watch List.
May 20, 2013
Wilmington, DE -- (SBWIRE) -- 05/20/2013 -- Equity Profile Report expands its NASDAQ Decliners Weekly Watch List adding Amarin Corporation plc (NASDAQ:AMRN), Theravance Inc. (NASDAQ:THRX), and Dendreon... Read More
from SBWire - Latest Press Releases
More Details about Hisun-Pfizer and Merck-Simcere JVs
May 20, 2013
In 2011, the world’s two largest drugmakers – Pfizer and Merck – each announced major China drug JVs with domestic China pharmas – Hisun in Pfizer’s case and Simcere for Merck. The arrangements were... Read More
from ChinaBio® Today
Pharma M&A – Actavis to Acquire Warner Chilcott
May 20, 2013
On Monday, generic drug maker Actavis Inc. (NYSE: ACT ) announced plans to purchase specialty pharmaceutical company Warner Chilcott (NASDAQ: WCRX ) in an all-stock deal valued around $8.5 billion.... Read More
category Benzinga , Global , VRX , and 8 more.
from Latest Articles from Benzinga.com
StockCall Pre-Market Review on AMRN, ARAY, ATRS, and ANTH
May 20, 2013
from ACCESSWIRE
UPDATE 3-Actavis to buy Warner Chilcott in $5 billion stock deal
May 20, 2013
May 20 (Reuters) - Generic drugmaker Actavis Inc, itself the subject of takeover speculation, said on Monday it would buy specialty pharmaceutical company Warner Chilcott Plc for $5 billion in stock to... Read More
category companyNews
from Reuters: Company News
Earnings Look Back: Vertex Pharmaceuticals Is Up 3.5% Since Reporting Quarterly Results 2 Weeks Ago (VRTX)
May 20, 2013
from Comtex SmarTrend® News Briefs
Critical Alerts For Wells Fargo, Alexion Pharmaceuticals, Cigna, Deckers Outdoor, and Yelp Released By InvestorsObserver
May 20, 2013
from PR Newswire
Orexigen Therapeutics Earnings Review: 12 Days after Announcement Shares Up 0.7% (OREX)
May 20, 2013
from Comtex SmarTrend® News Briefs
Isis Pharmaceuticals Earnings In Retrospect: Down 5.6% in the Last 13 Days (ISIS)
May 20, 2013
from Comtex SmarTrend® News Briefs
Earnings Look Back: Sucampo Pharmaceuticals Is Up 5.1% Since Reporting Quarterly Results 1 Week Ago (SCMP)
May 20, 2013
from Comtex SmarTrend® News Briefs
Depomed Earnings In Retrospect: Down 1.4% in the Last 12 Days (DEPO)
May 20, 2013
from Comtex SmarTrend® News Briefs
Pharmacyclics Earnings Review: 19 Days after Announcement Shares Up 11.3% (PCYC)
May 20, 2013
from Comtex SmarTrend® News Briefs
Teva Pharmaceutical Industries Earnings Hindsight: Up 6.4% in Last 18 Days (TEVA)
May 20, 2013
from Comtex SmarTrend® News Briefs
Post Earnings Update: Arena Pharmaceuticals Has Sunk 5.0% Lower in Past 2 Weeks (ARNA)
May 20, 2013
from Comtex SmarTrend® News Briefs
Earnings Look Back: Opko Health Is Up 3.5% Since Reporting Quarterly Results 1 Week Ago (OPK)
May 20, 2013
from Comtex SmarTrend® News Briefs
Allergan Earnings Review: 19 Days after Announcement Shares Up 0.7% (AGN)
May 20, 2013
from Comtex SmarTrend® News Briefs
20 Top Foreign Dividend Growth Stocks And Which To Consider
May 20, 2013
category IT Services & Computers
from Trefis
Pharma's R&D Deals With Foundations May Negatively Impact Image
May 20, 2013
On the surface, it sounds pretty reasonable. Foundations like the Michael J. Fox Foundation and the Cystic Fibrosis Foundation (CFF), in their attempts to accelerate the discovery and development of... Read More
category NASDAQ:VRTX , NYSE:PFE
from Forbes Real Time
Sangamo BioSciences Presents New Data From In Vivo Protein Replacement Platform For Development Of ZFP Therapeutics® For Monogenic Diseases
May 20, 2013
Production of Therapeutically Relevant Levels of Clotting Factor VIII Further Demonstrates Breadth and Leverage of this Novel Approach to Monogenic Diseases Read More
from PR Newswire
< Previous 1 2 3 4 5 6 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here